72700-07-3

Basic information

• Product Name: 3-Oxo-1-(4-dimethylamino-phenyl)-3-(3-hydroxy-phenyl)-propen-⁽¹⁾
• Synonyms: 3-Oxo-1-(4-dimethylamino-phenyl)-3-(3-hydroxy-phenyl)-propen-⁽¹⁾
• CAS NO: 72700-07-3
• Molecular Weight: 267.327
• Mol File: 72700-07-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-Oxo-1-(4-dimethylamino-phenyl)-3-(3-hydroxy-phenyl)-propen-⁽¹⁾(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Oxo-1-(4-dimethylamino-phenyl)-3-(3-hydroxy-phenyl)-propen-⁽¹⁾(72700-07-3)
• EPA Substance Registry System: 3-Oxo-1-(4-dimethylamino-phenyl)-3-(3-hydroxy-phenyl)-propen-⁽¹⁾(72700-07-3)

Safety Data

• Hazardous Substances Data: 72700-07-3(Hazardous Substances Data)

Upstream product

• 121-71-1 3-Hydroxyacetophenone 
• 100-10-7 4-dimethylamino-benzaldehyde 

Downstream Products

• 1421504-81-5 3-(5-(4-(dimethylamino)phenyl)-4,5-dihydroisoxazol-3-yl)phenol 

Relevant articles and documents

Differential Effects of Structural Modifications on the Competition of Chalcones for the PIB Amyloid Imaging Ligand-Binding Site in Alzheimer's Disease Brain and Synthetic Aβ Fibrils

Alzheimer's disease (AD) is a complex brain disorder that still remains ill defined. In order to understand the significance of binding of different clinical in vivo imaging ligands to the polymorphic pathological features of AD brain, the molecular chara

Mesomorphic study of novel chalconyl-ester-based nonisomeric series: Synthesis and characterization

A newly designed homologues series: 3-(3-(4-(Dimethylamino) phenyl) acrylonyl) phenyl 3-(4-n-alkoxyphenyl) acrylate has been synthesized and studied through chalconyl ester linking group at (meta) position. The series consists of 13 compounds, in which C1 to C4 homologue are nonliquid crystal, while C5 to C18 exhibit nematic phase, and C12 to C18 shows smectic and nematic phase with enantiotropically manner. Mesophase image of present compounds are rod like, needle and threaded type textures investigated by POM. All this compounds were characterized by elemental analysis, FT-IR and 1H NMR. The mesomorphism is measured by POM, DSC, and molecular packing is determined by XRD technique. The following synthesized chalconyl ester-based compounds C5 to C12 shows antibacterial as well as antifungal activity compared with corresponding standard drugs. Analytical and spectral data confirmed the molecular structures of homologous series.